bioRxiv Science⌕ Search

Biology subjects

Oommen, O. P.

Publications and source records attributed to Oommen, O. P..

2 recordsLinked to original sources

Genetically programmable molecular framework for constructing precision recombinant human ECM mimics

Engineering extracellular matrix (ECM) mimetic materials that combine molecular precision of synthetic material options with native biological complexity remains a central challenge in biomaterials science. Here, we present a genetically programmable hydrogel platform that enables independent control of mechanical and biological properties including matrix composition, mechanics, viscoelasticity, and biochemical signaling using recombinant human ECM building blocks assembled via isopeptide chemistry. Modular protein ECM crosslinkers containing complete folded ECM domains equipped with terminal SpyTag peptides were integrated within SpyCatcher-functionalized interchangeable natural polysaccharide backbones to generate fully defined matrices with decoupled material parameters. Point mutations on crosslinker SpyTags within the bond interface varied bond affinity from covalent to physical bonding, allowing tuned stress-relaxation behaviors across physiologically relevant regimes without altering matrix composition nor stiffness. Using colorectal cancer models, we show that polymer identity and matrix viscoelasticity independently regulate spheroid growth, invasion capabilities, and dispersion. Importantly, recombinant ECM domains recapitulated native adhesion functions and provide a structurally encoded layer of biological information. This hydrogel platform provides a molecular framework for constructing precision recombinant human ECM mimics with broad applicability across biomaterials science, mechanobiology, disease modeling, tissue engineering, and regenerative medicine.

bioengineering↗

Heparin-derived theranostic nanoprobes overcome the blood-brain barrier and target glioma in murine model

The poor permeability of theranostic agents across the blood-brain-barrier (BBB) significantly hampers the development of new treatment modalities for neurological diseases. We have discovered a new biomimetic nanocarrier using heparin (HP) that effectively passes the BBB and targets glioblastoma. Specifically, we designed HP coated gold nanoparticles (HP-AuNPs) that were labeled with three different imaging modalities namely, fluorescein (FITC-HP-AuNP), radioisotope 68Gallium (68Ga-HP-AuNPs), and MRI active gadolinium (Gd-HP-AuNPs). The systemic infusion of FITC-HP-AuNPs in three different mouse strains (C57BL/6JRj, FVB, and NMRI-nude) displayed excellent penetration and revealed uniform distribution of fluorescent particles in the brain parenchyma (69-86%) with some accumulation in neurons (8-18%) and microglia (4-10%). Tail-vein administration of radiolabeled 68Ga-HP-AuNPs in healthy rats also showed 68Ga-HP-AuNP inside the brain parenchyma and in areas containing cerebrospinal fluid, such as the lateral ventricles, the cerebellum, and brain stem. Finally, tail-vein administration of Gd-HP-AuNPs (that display [~]3 fold higher relaxivity than that of commercial Gd-DTPA) in an orthotopic glioblastoma (U87MG xenograft) model in nude mice demonstrated enrichment of T1-contrast at the intracranial tumor with a gradual increase in the contrast in the tumor region between 1h-3h. We believe, our finding offers the untapped potential of HP-derived-NPs to deliver cargo molecules for treating neurological disorders.

bioengineering↗